Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines.

Kattman SJ, Witty AD, Gagliardi M, Dubois NC, Niapour M, Hotta A, Ellis J, Keller G.

Cell Stem Cell. 2011 Feb 4;8(2):228-40. doi: 10.1016/j.stem.2010.12.008.

2.

Successful differentiation to T cells, but unsuccessful B-cell generation, from B-cell-derived induced pluripotent stem cells.

Wada H, Kojo S, Kusama C, Okamoto N, Sato Y, Ishizuka B, Seino K.

Int Immunol. 2011 Jan;23(1):65-74. doi: 10.1093/intimm/dxq458. Epub 2010 Dec 6.

PMID:
21135032
3.

A mesoderm-derived precursor for mesenchymal stem and endothelial cells.

Vodyanik MA, Yu J, Zhang X, Tian S, Stewart R, Thomson JA, Slukvin II.

Cell Stem Cell. 2010 Dec 3;7(6):718-29. doi: 10.1016/j.stem.2010.11.011.

4.

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ.

Cell Stem Cell. 2010 Nov 5;7(5):618-30. doi: 10.1016/j.stem.2010.08.012. Epub 2010 Sep 30.

5.

Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells.

Guenther MG, Frampton GM, Soldner F, Hockemeyer D, Mitalipova M, Jaenisch R, Young RA.

Cell Stem Cell. 2010 Aug 6;7(2):249-57. doi: 10.1016/j.stem.2010.06.015.

6.

Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells.

Polo JM, Liu S, Figueroa ME, Kulalert W, Eminli S, Tan KY, Apostolou E, Stadtfeld M, Li Y, Shioda T, Natesan S, Wagers AJ, Melnick A, Evans T, Hochedlinger K.

Nat Biotechnol. 2010 Aug;28(8):848-55. doi: 10.1038/nbt.1667. Epub 2010 Jul 19.

7.

Epigenetic memory in induced pluripotent stem cells.

Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LI, Yabuuchi A, Takeuchi A, Cunniff KC, Hongguang H, McKinney-Freeman S, Naveiras O, Yoon TJ, Irizarry RA, Jung N, Seita J, Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin SH, Weissman IL, Feinberg AP, Daley GQ.

Nature. 2010 Sep 16;467(7313):285-90. doi: 10.1038/nature09342.

8.

Reprogramming of human peripheral blood cells to induced pluripotent stem cells.

Staerk J, Dawlaty MM, Gao Q, Maetzel D, Hanna J, Sommer CA, Mostoslavsky G, Jaenisch R.

Cell Stem Cell. 2010 Jul 2;7(1):20-4. doi: 10.1016/j.stem.2010.06.002. No abstract available.

9.

Reprogramming of T cells from human peripheral blood.

Loh YH, Hartung O, Li H, Guo C, Sahalie JM, Manos PD, Urbach A, Heffner GC, Grskovic M, Vigneault F, Lensch MW, Park IH, Agarwal S, Church GM, Collins JJ, Irion S, Daley GQ.

Cell Stem Cell. 2010 Jul 2;7(1):15-9. doi: 10.1016/j.stem.2010.06.004. No abstract available.

10.

Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells.

Seki T, Yuasa S, Oda M, Egashira T, Yae K, Kusumoto D, Nakata H, Tohyama S, Hashimoto H, Kodaira M, Okada Y, Seimiya H, Fusaki N, Hasegawa M, Fukuda K.

Cell Stem Cell. 2010 Jul 2;7(1):11-4. doi: 10.1016/j.stem.2010.06.003. No abstract available.

11.

Generation of iPSCs from cultured human malignant cells.

Carette JE, Pruszak J, Varadarajan M, Blomen VA, Gokhale S, Camargo FD, Wernig M, Jaenisch R, Brummelkamp TR.

Blood. 2010 May 20;115(20):4039-42. doi: 10.1182/blood-2009-07-231845. Epub 2010 Mar 16.

12.

A nonviral minicircle vector for deriving human iPS cells.

Jia F, Wilson KD, Sun N, Gupta DM, Huang M, Li Z, Panetta NJ, Chen ZY, Robbins RC, Kay MA, Longaker MT, Wu JC.

Nat Methods. 2010 Mar;7(3):197-9. doi: 10.1038/nmeth.1426. Epub 2010 Feb 7.

13.

A chemical platform for improved induction of human iPSCs.

Lin T, Ambasudhan R, Yuan X, Li W, Hilcove S, Abujarour R, Lin X, Hahm HS, Hao E, Hayek A, Ding S.

Nat Methods. 2009 Nov;6(11):805-8. doi: 10.1038/nmeth.1393. Epub 2009 Oct 18.

14.

Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.

Ye Z, Zhan H, Mali P, Dowey S, Williams DM, Jang YY, Dang CV, Spivak JL, Moliterno AR, Cheng L.

Blood. 2009 Dec 24;114(27):5473-80. doi: 10.1182/blood-2009-04-217406. Epub 2009 Oct 1.

15.

Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors.

Choi KD, Vodyanik MA, Slukvin II.

J Clin Invest. 2009 Sep;119(9):2818-29. doi: 10.1172/JCI38591. Epub 2009 Aug 10.

16.

Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins.

Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, Ko S, Yang E, Cha KY, Lanza R, Kim KS.

Cell Stem Cell. 2009 Jun 5;4(6):472-6. doi: 10.1016/j.stem.2009.05.005. Epub 2009 May 28. No abstract available.

17.

Generation of induced pluripotent stem cells using recombinant proteins.

Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, Trauger S, Bien G, Yao S, Zhu Y, Siuzdak G, Schöler HR, Duan L, Ding S.

Cell Stem Cell. 2009 May 8;4(5):381-4. doi: 10.1016/j.stem.2009.04.005. Epub 2009 Apr 23. No abstract available. Erratum in: Cell Stem Cell. 2009 Jun 5;4(6):581.

18.

Human induced pluripotent stem cells free of vector and transgene sequences.

Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA.

Science. 2009 May 8;324(5928):797-801. doi: 10.1126/science.1172482. Epub 2009 Mar 26.

19.

Generation of induced pluripotent stem cells from human blood.

Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, Kim K, Miller JD, Ng K, Daley GQ.

Blood. 2009 May 28;113(22):5476-9. doi: 10.1182/blood-2009-02-204800. Epub 2009 Mar 18.

20.

Hematopoietic and endothelial differentiation of human induced pluripotent stem cells.

Choi KD, Yu J, Smuga-Otto K, Salvagiotto G, Rehrauer W, Vodyanik M, Thomson J, Slukvin I.

Stem Cells. 2009 Mar;27(3):559-67. doi: 10.1634/stemcells.2008-0922.

Supplemental Content

Support Center